A
AIM
Aim Immunotech
0.5950
+0.0450+8.18%After Hours: 0.5711 -0.0239 -4.02%19:42 04/02 EDT
OPEN/PREV CLOSE0.5457/0.5500
TODAY RANGE0.5400-0.6099
VOL203.80K
MARKET CAP4.85M
52 WEEK RANGE0.5300-34.89
AVG VOL (3M)4.55M
% TURNOVER2.50%
TURNOVER--
P/E (TTM)-0.0690
% RANGE12.71%
EPS(TTM)-8.6234
P/E(FORWARD)-0.1376
P/B-0.1867
BVPS-3.1868
DIVIDEND--
P/S2.296
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.42M
SHARES OUTSTANDING8.15M
NEXT EARNINGS05/13-05/18
FREE FLOAT4.06M
LOT SIZE1
EX-DATE02/10/2026
News
Press Releases
Financial Reports
Profile
Benzinga·03/24 11:11
Earnings Scheduled For March 24, 2026
Benzinga·03/20 15:08
What's Going On With AIM ImmunoTech Stock Friday?
TipRanks·03/20 14:55
Biotech Alert: Searches spiking for these stocks today
TipRanks·03/19 14:11
3 Penny Stocks to Watch Now, 3/19/26
Benzinga·03/19 12:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·03/19 12:03
Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga·03/19 09:48
Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
TipRanks·03/18 17:23
Morning News Wrap-Up 3/18/26: Today’s Biggest Stock Market Stories!
Benzinga·03/18 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·03/18 16:08
Why Is AIM ImmunoTech Stock Gaining Today?
Benzinga·03/18 16:04
Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results
Benzinga·03/18 13:50
Dow Falls Over 150 POints; US Producer Prices Increase In February
TipRanks·03/18 13:47
Why Is AIM ImmunoTech Stock (AIM) Up Today?
TipRanks·03/18 12:51
AIM announces approval of patent for Ampligen in Japan
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.